News

Kennedy Jr. and the Food and Drug Administration announced a plan to phase out petroleum-based dyes ... artificial food dyes from the American diet. The Health and Human Services Department ...
But if your hand is already straying towards the biscuits at the thought of yet another boring diet - stop ... The carbohydrate-sensitive plan Phase 1 - week 1 (Total daily carbs allowed: 20g ...
Eli Lilly has seen positive results from a phase 3 trial of Orforglipron, the first-ever GLP-1 pill for weight loss and type ...
Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...
KIITEE Phase 1 Results 2025 has been declared at kiitee.kiit.ac.in. The direct link to check is given below. The Kalinga Institute of Industrial Technology, KIIT, has declared the KIITEE 2025 ...
The Kalinga Institute of Industrial Technology has released the KIITEE 2025 Phase 1 results for its entrance exam. Candidates can now check their scores, subject-wise marks, and overall rank ...
LEXINGTON, Mass., March 31, 2025 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on ...
The first patient with small cell lung cancer has been dosed in a phase 1/2 trial investigating first-line iadademstat plus ...
Drugmaker Eli Lilly said that in Phase 3 studies of over 550 adults, their oral GLP-1 pill, orforglipron, could reduce ...
The phase III ACHIEVE-1 study ... also showing statistically significant weight loss. The overall safety profile of orforglipron in the ACHIEVE-1 study aligned with that of other GLP-1 therapies.